Gene · 406902
Papers3,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional Foods as Modulators of Epigenetic Mechanisms Affecting Metabolic Health in Adolescence. | Int J Mol Sci | 2026 | 41752200 | PubTator, text mining | PubMed |
| Dermal Fibroblast Senescence: The Central Hub of Skin Aging-From Intrinsic Dysfunction to Microenvironmental Remodeling. | Int J Mol Sci | 2026 | 41751788 | PubTator, text mining | PubMed |
| miRNA-Based Breast Cancer Subtyping Using AHALA Multi-Stage Classification Approach. | Cancers (Basel) | 2026 | 41749839 | PubTator, text mining | PubMed |
| Extracellular vesicles in rheumatoid arthritis: emerging roles in progression, diagnosis, and therapeutic development. | Front Immunol | 2026 | 41743711 | PubTator, text mining | PubMed |
| WWC proteins as emerging biomarkers and therapeutic targets in cancer pathogenesis. | Front Cell Dev Biol | 2026 | 41727322 | PubTator, text mining | PubMed |
| Biomaterial-assisted gene therapy for bone repair. | Mater Today Bio | 2026 | 41716342 | PubTator, text mining | PubMed |
| miR-10a Delivered via MSC-derived Extracellular Vesicles Modulates Inflammation in a CCl4-induced Liver Fibrosis Model. | Iran J Allergy Asthma Immunol | 2026 | 41674168 | PubTator, text mining | PubMed |
| IL-10+ regulatory B lymphocytes are impacted by intradermal PBMCs therapy in patients with unexplained recurrent pregnancy loss (uRPL). | Curr Res Transl Med | 2026 | 41621190 | PubTator, text mining | PubMed |
| MicroRNA‑microbiome cross‑kingdom networks drive inflammatory bowel disease through dynamic regulatory ecosystems (Review). | Int J Mol Med | 2026 | 41614418 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| A Pilot Study Profiling Aqueous Humor-Derived Exosomal MicroRNA in Primary Open-Angle and Exfoliation Glaucoma. | Ophthalmol Sci | 2026 | 41552653 | PubTator, text mining | PubMed |
| Helicobacter pylori and Cancer: What's the Link? | Clin Exp Gastroenterol | 2026 | 41531650 | PubTator, text mining | PubMed |
| A smoothing method for DNA methylome analysis to enhance epigenomic signature detection in epigenome-wide association studies. | Methods | 2026 | 41274433 | PubTator, text mining | PubMed |
| Intrinsic MicroRNA-10a Restricts Regulatory T Cell Suppressive Function and Intestinal Repair by Coordinating Transcriptional, Metabolic, and Epithelial Repair Pathways. | Adv Sci (Weinh) | 2026 | 41178490 | PubTator, text mining | PubMed |
| MiR-10a as a Potential Biomarker and Therapeutic Target in Localized and Metastatic Prostate Cancer. | Curr Issues Mol Biol | 2025 | 41296417 | PubTator, text mining | PubMed |
| MiRNome alterations drive the malignant transformation of endometriosis into endometriosis-correlated ovarian cancer. | Sci Rep | 2025 | 41271954 | PubTator, text mining | PubMed |
| Correction: miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia. | Leukemia | 2025 | 41107617 | PubTator, text mining | PubMed |
| Navigating the Landscape of Exosomal microRNAs: Charting Their Pivotal Role as Biomarkers in Hematological Malignancies. | Noncoding RNA | 2025 | 40981381 | PubTator, text mining | PubMed |
| Distinct expression profiles of hsa-miR-31, hsa-miR-29c, hsa-miR-17, and hsa-miR-10a in oral epithelial dysplasia and squamous cell carcinoma. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2025 | 40957750 | PubTator, text mining | PubMed |
| Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trial. | Signal Transduct Target Ther | 2025 | 40954146 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406902/papers?page=2